SOUTHEAST TECHINVENTURES, INC.

DURHAM, NC · CIK 0001272667 · Biotech · Private

Small molecule therapeutics targeting lipid metabolism for non-alcoholic fatty liver disease (NAFLD)

southeasttechinventures.com →
Grants
$895K
1 award
Sector median: 1
Raised
$836K
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Novel therapeutics for fatty liver disease and type-II diabetes$895,454
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2577Thiogenesis Therapeutics, Corp.—$878K
2578Gradient Pharmaceuticals, Inc.—$850K
2579Chemistry Holdings, Inc.—$845K
2580SOUTHEAST TECHINVENTURES, INC.—$836K
2581RAPHAEL PHARMACEUTICALS LLC——
2582KaloCyte Inc—$800K
2583Metagenomi——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • John DurenDirector
  • William LawsonDirector
  • Karen LeVertDirector · Executive Officer
  • Chongchang MaoDirector · Executive Officer
  • David RizzoDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.